The year before Evelyn Hampton was born, the first study appeared linking talc to ovarian cancer. But neither she nor her family were warned about this association. Instead they trusted Johnson & Johnson when the company promoted its talcum powder products as safe enough for everyday use. Hampton became a loyal customer.
By 1982, when Hampton was 10, researchers conducted the first epidemiological study on genital use of talcum powder for feminine hygiene and found that women who used talc in this fashion had a 92 percent greater risk of developing ovarian cancer, Hampton claims. One scientist, Daniel Cramer, even advised Johnson & Johnson that it place warnings on its talcum powder products so that consumers could make informed choices about whether to use the product. Johnson & Johnson refused.
In the years that followed, 22 additional epidemiological studies have been conducted investigating talc’s link to ovarian cancer. The risk of developing the deadly disease among talc users was found to be between 27 and 379 percent, Hampton claims.
In 1999, when Hampton was 27, Cramer conducted a second study on 563 women newly diagnosed with epithelial ovarian cancer and compared them to 523 women without cancer. He found a 60 percent increased risk of ovarian cancer in women who used talcum powder on their genitals.
In 2016, when Hampton was 44, she was diagnosed with ovarian cancer. She is now suing Johnson & Johnson for falsely and unfairly advertising its Johnson’s Baby Powder and Shower to Shower body powder as beacons of cleanliness and purity, especially since the company allegedly knew since before she was born that genital use of talc could cause ovarian cancer.
Source: Lexis Legal News